drugset

drugset / Trial / NCT03949049

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

NCT03949049 ↗

Phase 3 Recruiting 40 enrolled Tanta University

RandomizedParallel-groupDouble-blindTreatment

Summary

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Timeline

Start: 2019-02-01
Primary completion: 2029-12-01
Completion: 2029-12-01

Publications

Salamah A, El Amrousy D, Elsheikh M, Mehrez M. Citicoline in hypoxic ischemic encephalopathy in neonates: a randomized controlled trial. Ital J Pediatr. 2023 May 12;49(1):55. doi: 10.1186/s13052-023-01452-5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Citicoline	Other / unclassified	10 mg/kg	Intravenous

Indications